$5MSeries A, 15 January 2026
Equity portion of a CA$10M package (CA$3M venture debt from CIBC Innovation Banking) to grow B2B and build a hormone operating system.
- Amount
- $5M
- Stage
- Series A
- Announced
- 15 January 2026
- Lead
- Pender Ventures
- Other investors
- WELL Health Technologies, Michele Romanow
- Use of funds
- Equity portion of a CA$10M package (CA$3M venture debt from CIBC Innovation Banking) to grow B2B and build a hormone operating system.
- Checked
- Amount and date checked against the press source
- Source
- Science&Humans raises $10 million as hormone health enters the mainstream betakit.com